CD1-MR1 2017* , ,
Presentations this author is a contributor to:
Investigating anti-lymphoma effects of human CD4+ iNKT cells in vivo: effectors or adjuvants? (#63)
2:30 PM
Jenny E Gumperz
Session 9: Cancer and immunotherapy